ArticleJournal for immunotherapy of cancer2023

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors.

Clémence Demerlé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.